FDA Approved: SUMATRIPTAN — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Sumatriptan from Bionpharma Inc. under the ANDA program, updating the regulatory status of the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan (Sumatriptan)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN)